<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Cardinal Health Company Newsfeed</title>
<link>http://www.advfn.com/nyse/rss.asp?symbol=CAH</link>
<description>Cardinal Health Company Newsfeed</description>
<language>en</language>
<pubDate>Thu, 02 May 2013 08:20:07 EDT</pubDate>
<lastBuildDate>Thu, 02 May 2013 08:20:07 EDT</lastBuildDate>
  
  
 <item>
 <title>Cardinal Health Profit Rose 3.6%; Dividend Raised</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57409376&amp;headline=cardinal-health-profit-rose-3-6-dividend-raised</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57409376&amp;headline=cardinal-health-profit-rose-3-6-dividend-raised</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Cardinal Health Inc.'s (CAH) fiscal third-quarter earnings rose 3.6% amid a tax benefit and as stronger margins offset lower pharmaceutical sales revenue. &#60;/p&#62;
&#60;p&#62; For the fiscal year, the company raised its per-share earnings estimate to $3.67 to $3.71, from its previous estimate...</description>
 <pubDate>Thu, 02 May 2013 08:20:07 EDT</pubDate>
 </item>

 <item>
 <title>Cardinal Health Third-Quarter Profit Rose 3.6%; Dividend Raised</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57408874&amp;headline=cardinal-health-third-quarter-profit-rose-3-6-dividend-raised</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57408874&amp;headline=cardinal-health-third-quarter-profit-rose-3-6-dividend-raised</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Tess Stynes &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc.'s (CAH) fiscal third-quarter earnings rose 3.6% amid a tax benefit and as stronger margins offset lower pharmaceutical sales revenue. &#60;/p&#62;
&#60;p&#62; For the fiscal year, the company raised its per-share earnings estimate to $3.67 to...</description>
 <pubDate>Thu, 02 May 2013 08:00:12 EDT</pubDate>
 </item>

 <item>
 <title>Cardinal, McKesson Renew Distribution Agreements With CVS</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57320846&amp;headline=cardinal-mckesson-renew-distribution-agreements-with-cvs</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=57320846&amp;headline=cardinal-mckesson-renew-distribution-agreements-with-cvs</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Saabira Chaudhuri &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc. (CAH) and rival McKesson Corp. (MCK) have separately renewed distribution agreements with a major customer, CVS Caremark Corp. (CVS), lifting a shadow for both drug wholesalers who count CVS as a major customer. &#60;/p&#62;
&#60;p&#62;...</description>
 <pubDate>Thu, 25 Apr 2013 08:21:03 EDT</pubDate>
 </item>

 <item>
 <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56807982&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56807982&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Among the companies with shares expected to actively trade in Tuesday's session are AmerisourceBergen Corp. (ABC), Cardinal Health Inc. (CAH) and Affymax Inc. (AFFY). &#60;/p&#62;
&#60;p&#62; Walgreen Co. (WAG) and Alliance Boots GmbH agreed to get their branded and generic pharmaceutical products...</description>
 <pubDate>Tue, 19 Mar 2013 09:25:51 EDT</pubDate>
 </item>

 <item>
 <title>Cardinal Health Borrows $1.3 Billion for AssuraMed Buy</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56368716&amp;headline=cardinal-health-borrows-1-3-billion-for-assuramed-buy</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56368716&amp;headline=cardinal-health-borrows-1-3-billion-for-assuramed-buy</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Cardinal Health Inc. (CAH) is borrowing $1.3 billion Tuesday to help pay for its $2.07 billion acquisition of medical supplier AssuraMed. &#60;/p&#62;
&#60;p&#62; The acquisition was announced last Thursday. AssuraMed serves more than one million patients annually, offering more than 30,000...</description>
 <pubDate>Tue, 19 Feb 2013 15:30:09 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health Borrowing $1.3 Billion to Acquire AssuraMed</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56368522&amp;headline=cardinal-health-borrowing-1-3-billion-to-acquire-assuramed</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56368522&amp;headline=cardinal-health-borrowing-1-3-billion-to-acquire-assuramed</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Patrick McGee &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc. (CAH) is borrowing $1.3 billion Tuesday to help pay for its $2.07 billion acquisition of medical supplier AssuraMed. &#60;/p&#62;
&#60;p&#62; The acquisition was announced last Thursday. AssuraMed serves more than one million patients annually...</description>
 <pubDate>Tue, 19 Feb 2013 15:14:18 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health to Buy AssuraMed for $2.07 Billion</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56295068&amp;headline=cardinal-health-to-buy-assuramed-for-2-07-billion</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56295068&amp;headline=cardinal-health-to-buy-assuramed-for-2-07-billion</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Cardinal Health Inc. (CAH) agreed to acquire closely held medical-supplies provider AssuraMed for $2.07 billion as the drug wholesaler looks to diversify its offerings. &#60;/p&#62;
&#60;p&#62; AssuraMed currently serves more than one million patients nationally with more than 30,000 products...</description>
 <pubDate>Thu, 14 Feb 2013 08:40:07 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health to Buy Medical-Supplies Provider AssuraMed for...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56294594&amp;headline=cardinal-health-to-buy-medical-supplies-provider-assuramed-for</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56294594&amp;headline=cardinal-health-to-buy-medical-supplies-provider-assuramed-for</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Melodie Warner &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc. (CAH) agreed to acquire closely held medical-supplies provider AssuraMed for $2.07 billion as the drug wholesaler looks to diversify its offerings. &#60;/p&#62;
&#60;p&#62; AssuraMed currently serves more than one million patients nationally...</description>
 <pubDate>Thu, 14 Feb 2013 08:23:17 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health Profit Up 16% on Improved Margins</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56147286&amp;headline=cardinal-health-profit-up-16-on-improved-margins</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56147286&amp;headline=cardinal-health-profit-up-16-on-improved-margins</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Cardinal Health Inc.'s (CAH) fiscal second-quarter earnings rose 16% as the drug wholesaler reported improved margins that helped to offset weaker revenue at its pharmaceutical division, which was caused partly by generic-drug introductions. &#60;/p&#62;
&#60;p&#62; For the year, the second-biggest...</description>
 <pubDate>Tue, 05 Feb 2013 08:40:22 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health 2nd-Quarter Profit Up 16% on Improved Margins</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56146939&amp;headline=cardinal-health-2nd-quarter-profit-up-16-on-improved-margins</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56146939&amp;headline=cardinal-health-2nd-quarter-profit-up-16-on-improved-margins</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Tess Stynes &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc.'s (CAH) fiscal second-quarter earnings rose 16% as the drug wholesaler reported improved margins that helped to offset weaker revenue at its pharmaceutical division, which was caused partly by generic-drug introductions. &#60;/p&#62;
&#60;p&#62;...</description>
 <pubDate>Tue, 05 Feb 2013 08:30:05 EST</pubDate>
 </item>

 <item>
 <title>CORRECT: Cardinal Health Sees $79 Million in Costs From Production...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56072984&amp;headline=correct-cardinal-health-sees-79-million-in-costs-from-production</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56072984&amp;headline=correct-cardinal-health-sees-79-million-in-costs-from-production</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; (&#34;Cardinal Health Sees $79 Million in Costs from Production Move,&#34; published at 6:07 p.m. EDT, misstated the source of eliminating 80 positions and the company's workforce. The company is eliminating 80 positions from as part of its medical-segment reorganization, not the sale...</description>
 <pubDate>Wed, 30 Jan 2013 19:44:24 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health Sees $79 Million in Costs from Production Move</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56072702&amp;headline=cardinal-health-sees-79-million-in-costs-from-production-move</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56072702&amp;headline=cardinal-health-sees-79-million-in-costs-from-production-move</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp &#60;/pre&#62;
&#60;p&#62; Drug wholesaler Cardinal Health Inc. (CAH) on Wednesday said shifting the production of procedure kits, along with other planned restructuring, will cost $79 million and result in the elimination of 180 positions. &#60;/p&#62;
&#60;p&#62; Cardinal Health plans to move...</description>
 <pubDate>Wed, 30 Jan 2013 18:37:32 EST</pubDate>
 </item>

 <item>
 <title>AmerisourceBergen Signs New Deal With Big Customer PharMerica</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56063881&amp;headline=amerisourcebergen-signs-new-deal-with-big-customer-pharmerica</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=56063881&amp;headline=amerisourcebergen-signs-new-deal-with-big-customer-pharmerica</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp &#60;/pre&#62;
&#60;p&#62; Drug wholesaler AmerisourceBergen Corp. (ABC) has signed a new deal extending its relationship with a top customer, the nursing-home pharmacy PharMerica Corp. (PMC). &#60;/p&#62;
&#60;p&#62; According to a regulatory filing from PharMerica Wednesday, the company entered...</description>
 <pubDate>Wed, 30 Jan 2013 09:49:57 EST</pubDate>
 </item>

 <item>
 <title>Glaxo in $150 Million Settlement in Generic Nasal Spray Case</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=55535263&amp;headline=glaxo-in-150-million-settlement-in-generic-nasal-spray-case</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=55535263&amp;headline=glaxo-in-150-million-settlement-in-generic-nasal-spray-case</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; GlaxoSmithKline PLC (GSK) has agreed to a $150 million settlement with a group of drug wholesalers who said the drug maker delayed the introduction of generic alternatives to Flonase nasal spray, Reuters reported Wednesday, citing court documents. &#60;/p&#62;
&#60;p&#62; AmerisourceBergen...</description>
 <pubDate>Wed, 19 Dec 2012 14:00:25 EST</pubDate>
 </item>

 <item>
 <title>GlaxoSmithKline in $150 Million Settlement in Generic Nasal Spray...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=55535070&amp;headline=glaxosmithkline-in-150-million-settlement-in-generic-nasal-spray</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=55535070&amp;headline=glaxosmithkline-in-150-million-settlement-in-generic-nasal-spray</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; GlaxoSmithKline PLC (GSK) has agreed to a $150 million settlement with a group of drug wholesalers who claimed the drug maker delayed the introduction of generic alternatives to Flonase nasal spray, Reuters reported Wednesday, citing court documents. &#60;/p&#62;
&#60;p&#62; AmerisourceBergen...</description>
 <pubDate>Wed, 19 Dec 2012 13:45:34 EST</pubDate>
 </item>

 <item>
 <title>Cardinal Health: DOJ Requested Documents on Customer Discounts</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54945620&amp;headline=cardinal-health-doj-requested-documents-on-customer-discounts</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54945620&amp;headline=cardinal-health-doj-requested-documents-on-customer-discounts</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc. (CAH) disclosed Friday that the Department of Justice has required the pharmaceutical wholesaler to produce documents involving customer discounts. &#60;/p&#62;
&#60;p&#62; The company received a civil investigative demand from the DOJ in September...</description>
 <pubDate>Fri, 09 Nov 2012 09:23:14 EST</pubDate>
 </item>

 <item>
 <title>Fitch Lowers Outlook for Cardinal Health to Stable on Growth...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54884936&amp;headline=fitch-lowers-outlook-for-cardinal-health-to-stable-on-growth</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54884936&amp;headline=fitch-lowers-outlook-for-cardinal-health-to-stable-on-growth</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Debbie Cai &#60;/pre&#62;
&#60;p&#62; Fitch Ratings has revised its ratings outlook on Cardinal Health Inc. (CAH) to stable from positive, citing steady pharmaceutical demand amid concerns around medium-term growth. &#60;/p&#62;
&#60;p&#62; The ratings firm said Cardinal's market position allows for a...</description>
 <pubDate>Tue, 06 Nov 2012 14:11:34 EST</pubDate>
 </item>

 <item>
 <title>Correction to Tuesday's Cardinal Health Earnings Story</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54766775&amp;headline=correction-to-tuesdays-cardinal-health-earnings-story</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54766775&amp;headline=correction-to-tuesdays-cardinal-health-earnings-story</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; &#34;Cardinal Health's 1st-Quarter Profit Up 14% on Lower Costs; Unveils Dividend Increase,&#34; published Tuesday at 7:44 a.m. EDT, incorrectly said in the 10th paragraph that distribution, selling, general and administrative expenses shrank 7.1%, when in fact these expenses rose 7.1...</description>
 <pubDate>Wed, 31 Oct 2012 11:14:28 EDT</pubDate>
 </item>

 <item>
 <title>Cardinal Health's 1st-Quarter Profit Up 14% on Lower Costs; Unveils...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54746052&amp;headline=cardinal-healths-1st-quarter-profit-up-14-on-lower-costs-unveils</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54746052&amp;headline=cardinal-healths-1st-quarter-profit-up-14-on-lower-costs-unveils</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Tess Stynes and Saabira Chaudhuri &#60;/pre&#62;
&#60;p&#62; Cardinal Health Inc.'s (CAH) fiscal first-quarter earnings rose 14% as the company saw its expenses fall, masking a decline in revenue. &#60;/p&#62;
&#60;p&#62; Cardinal Health, the second-biggest drug distributor in the U.S. by sales, had reported...</description>
 <pubDate>Tue, 30 Oct 2012 11:43:02 EDT</pubDate>
 </item>

 <item>
 <title>McKesson Renews Drug-Supply Deal With Large Customer Rite Aid</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54404543&amp;headline=mckesson-renews-drug-supply-deal-with-large-customer-rite-aid</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=CAH&amp;article=54404543&amp;headline=mckesson-renews-drug-supply-deal-with-large-customer-rite-aid</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp &#60;/pre&#62;
&#60;p&#62; Drug-wholesaler McKesson Corp. (MCK) has renewed its supply deal with pharmacy chain Rite Aid Corp. (RAD), its second-largest customer, in a new agreement that is set to stretch into 2016. &#60;/p&#62;
&#60;p&#62; The renewal came earlier than expected, according to...</description>
 <pubDate>Thu, 04 Oct 2012 09:07:48 EDT</pubDate>
 </item>

</channel>
</rss>